MENU

2019 Drug Survey shows drug use prevalence rate falls to 2.05%

81.6% approves of the government’s anti-drug campaign

Around 1.67 million or two out of one hundred Filipinos aged 10 to 69 are current users of drugs, according to the results of the 2019 National Household Survey on the Patterns and Trends of Drug Abuse, released by the Dangerous Drugs Board.

Read more ...

DDB urges courts to adopt regulation on destruction of seized illegal drugs

In a letter to the Supreme Court, the Dangerous Drugs Board reiterated the implementation of Board Regulations on the disposition of confiscated dangerous drugs, controlled precursors and essential chemicals, paraphernalia and laboratory equipment used for the manufacture of illegal substances.

Read more ...

DDB issues guidelines to clear jails of illegal drugs

Controlled facilities or jails nationwide are directed to clear its premises from illegal drug activities and secure their drug-cleared or drug-free status, twelve months from now.

Read more ...

DDB responds to the Statement of the UN High Commissioner for Human Rights on the global human rights update

The Dangerous Drugs Board reiterates to the the UN High Commissioner for Human Rights that no policies have to be revoked because there are none which permit, tolerate, and condone killings and other human rights violations in relation to the Philippines’s anti-drug campaign.

Read more ...

DDB provides funding support to Ormoc, BARMM LGU and La Union DOH-TRC

Three beneficiaries received a grant of 5 Million Pesos each from the Dangerous Drugs Board to aid the construction of in-patient and community-based drug treatment and rehabilitation facilities in their respective localities.

Read more ...

Statement of the Dangerous Drugs Board on the Vape Product Containing Marijuana

The Dangerous Drugs Board (DDB) affirms and reiterates the warning issued by the Food and Drug Administration (FDA) against the purchase and use of a vapor product refill, bearing the brand name “Gluttony” and flavor “Mamon,” found to contain cannabinol.

Read more ...

DDB sets regulatory control requirements for Lianhua Qingwen capsules

In emphasizing a balanced national drug control program as a priority, the Dangerous Drugs Board sets the regulatory control requirements for Lianhua Qingwen capsules recently approved by the Food and Drug Administration.

Read more ...

Admission to drug treatment and rehabilitation centers to resume with strict health and safety protocols amid the pandemic

Adjusting to the “New Normal,” the Dangerous Drugs Board (DDB) adopted infection prevention and control protocol to be followed upon the resumption of admissions and activities in drug treatment and rehabilitation facilities nationwide.

Read more ...

DDB issues policy to ensure availability of physicians authorized to assess substance use disorder amid the pandemic

The Dangerous Drugs Board, in its recent special meeting, approved a Resolution extending the validity of provisional accreditation granted to physicians authorized to conduct Drug Dependency Examination (DDE) for a period of two years.

Read more ...